Ted Love
Board Member
Jazz Pharmaceuticals plc (JAZZ)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ted Love
Ted Love is recorded as Board Member at Jazz Pharmaceuticals plc (JAZZ). Jazz Pharmaceuticals plc reported in an 8-K filed October 28, 2025 that Ted Love was appointed Class I director, effective December 1, 2025.
“On October 23, 2025, the board of directors (the "Board") of Jazz Pharmaceuticals plc (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Ted Love to the Board, effective as of December 1, 2025, as a Class I director for a term expiring at the annual general meeting of shareholders to be held in 2027.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-12-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Jazz Pharmaceuticals plc
Other people whose current roles at this company are on record from its filings.
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.